Aducanumab: What About the Patient?; Risk of Aneurysm Rupture After Stroke Thrombolysis
Neurology® Podcast
00:00
Is There a Risk of Side Effects of the Drug?
The drug is designed to remove amaloid from the brain, an it seems to do that in the climical trials. But it also may remove amaloids from the blood vessels. Since amalid is deposited in the blood vessels not infrequently in people who have al sams diseased. When you do that, blood vessels might become leaky and might lead to edema, might lead to hemorrhage in the brain.
Transcript
Play full episode
